Definition
An extranodal lymph showing a wide morphological spectrum. There is commonly angiocentricity, vascular destruction and necrosis. While most cases are of NK-cell type, some appear to be composed of cytotoxic g/d T-cells.
The median patient age is about fifty years2,4. Most common in Asia (Japan4, Korea and China), it is also relatively common in Mexico, South and Central America2, where it occurs in adults with a male predominance. It has also been reported in immunosuppressed and post-transplantation patients. EBV is probably pathogenic. Cases complicating transplantation have been reported.
Involvement is most commonly of the nasal cavity, nasopharynx and palate, also of skin, soft tissues, gastrointestinal tract and testes. There may be secondary lymph node involvement. Marrow involvement is uncommon, but there may be overlap with aggressive NK leukaemia.
Patients present with nasal obstruction, epistaxis or midfacial destructive lesions. Rapid dissemination may occur. There may be a haemophagocytic syndrome, which is often a late clinical complication associated with a rapidly fatal outcome2.
Cutaneous cases may be solitary but are usually generalised, consisting of tumours, ulcer, or vasculitis/panniculitis. There is commonly a haemophagocytic syndrome1.
At all sites, there is mucosal ulceration. There is a diffuse lymphomatous infiltrate with angiocentricity and angiodestruction. Fibrinoid necrosis of vessel walls may be seen. Massive coagulative necrosis is common4 and there is often marked apoptosis4. The neoplastic cells vary from small to large and anaplastic. The nuclei tend to be somewhat elongated, so-called cleaved-like cells, admixed with large blastic cells with round nuclei4. An abundant admixture of small lymphocytes, plasma cells, histiocytes and eosinophils may be present, mimicking an inflammatory process.
Cutaneous disease is often "bottom-heavy" with extension into subcutaneous fat. Epidermotropism is rare but an overlying florid pseudoepitheliomatous hyperplasia may mimic carcinoma.
positive2, 9/204 |
||
surface-negative but cytoplasmic e-positive2, 31/314 |
||
usually negative, 0/314 |
||
usually negative, 0/304 |
||
occasionally positive, 7/204 |
||
usually negative, 3/314 |
||
may be positive |
||
usually negative2, 0/204 |
||
0/314 |
||
occasionally positive |
||
usually positive, 23/314 |
||
usually positive, 24/314 |
||
positive2 (unless cytotoxic T-cell type), 29/314 |
||
usually negative2 |
||
TCR |
usually negative, 0/204 |
|
granzyme B |
usually positive2, 30/314 |
|
usually positive2, 30/304 |
||
perforin |
usually positive2 |
|
TCR |
usually negative, unless composed of NK-like T-cells |
|
EBV |
positive, 12/314 |
|
6q deletions are common2. T-cell gene rearrangements are lacking.
Molecular studies
T-cell receptor b gene rearrangement: 0/74
T-cell receptor g gene rearrangement: 1/74
CD56-positive peripheral T-cell lymphoma
While lymphomas of the nasal cavity are of NK type, those in the paranasal sinuses are more often of B-cell origin4.
Radiotherapy may be effective for localised disease, but is usually combined with chemotherapy2. Expression of high levels of multidrug resistance gene confers resistance to chemotherapy2.
Nasal disease is of very variable prognosis with a reported 5-year survival of 58%4. Stage I disease has a favourable prognosis4. Extra-nasal disease is highly aggressive. There is frequently deletion or mutation of p53, but this does not appear to be of prognostic significance2. Expression of CD94 may be associated with a better prognosis3.
World Health Organization Classification of Tumours, Tumours of the haematopoietic and lymphoid tissues, IARC Press 2001.
This page last revised 19.12.2005.
©SMUHT/PW Bishop